Ayurcann Holdings Corp., an award-winning Canadian cannabis extraction company, has announced its merger with Arogo Capital Acquisition Corp., amounting to a combined enterprise value estimated at $210 million. The transaction positions Ayurcann to further cement its market leadership in cannabis 2.0 and 3.0 products, particularly in Ontario, where it is the top producer of vapes and a major pre-roll manufacturer. Post-combination, Ayurcann is expected to have up to $19.6 million in cash on its balance sheet. The deal is set to close in the second half of 2024, pending regulatory approvals and customary closing conditions. Legal and financial advisors involved include Brown Rudnick LLP, Fasken Martineau DuMoulin LLP, Sichenzia Ross Ference Carmel LLP, Garfinkle Biderman LLP, ARC Group Limited, and EF Hutton.

Cannabis, Finance,Canada, United States